Search results

Sort by:

Filter by:

  1. ATLABi001-A (AT-MODY3-iP001)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes

  2. ATLABi002-A (AT-MODY3-iP002)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes

  3. ATLABi006-A (AT-UC C Normal-iC16)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  4. ATLABi007-A (AT-UC C Normal-iC46)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  5. ATLABi008-A (AT-UC I Normal-iC06)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  6. ATLABi009-A (AT-UC I Normal-iC13)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  7. ATLABi010-A (AT-MODY10-iII1)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  8. ATLABi011-A (AT-MODY10-iII4)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  9. ATLABi012-A (AT-M10 Normal-iI2)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  10. ATLABi013-A (AT-M10 Normal-iII3)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Normal

  11. ATLABi014-A (AT-MODY10-iI1)

    Singapore IMCB, Adrian Teo's Lab (ATLAB)
    Disease:

    Maturity-onset diabetes of the young type 10

  12. BCMi001-A (M22c5 and HSCC-003iPS-Sc5)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal

  13. BCMi001-B (M22c8 and HSCC-003iPS-Sc8)

    United States Baylor College of Medicine (BCM)
    Disease:

    Normal

  14. CHAe001-A (CHA-hES3)

    South Korea Pochon CHA University (CHA)
  15. CSUe004-A (chHES-20)

    China Central South University (CSU)
  16. CSUe005-A (chHES-22)

    China Central South University (CSU)
  17. WAe009-A-10 (EBNA1+H9 and H9-EBNA)

    China Central South University (CSU)
    Disease:

    Normal

  18. DALCe001-A (ReliCellhES1)

    India Dhirubhai Ambani Life Sciences Center (DALC)
  19. DANi006-F (GBA-006-C6)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  20. DANi008-F (SNCA-008-C6)

    Denmark Danish Research Institute of Translational Neuroscience (DAN)
    Disease:

    Parkinson's disease

  21. ESi049-A (MS FiPS 2 R4F-10)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsolete_multiple sclerosis

  22. ESi050-A (MS FiPS 3-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  23. ESi051-A (MS FiPS 4-R4F-1)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Obsolete_multiple sclerosis

  24. ESi052-A (MS FiPS 5-R4F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  25. ESi053-A (MS FiPS 6-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Multiple sclerosis

  26. ESi068-A (SWB FiPS 159-R4F-4)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams-beuren syndrome

  27. ESi069-A (SWB FiPS 344-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Williams-beuren syndrome

  28. ESi070-A (DUPSW FiPS 501-R4F-2)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  29. ESi071-A (DUPSW FiPS 701-R4F-6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Autism

  30. ESi094-A (Hz 1-8-3 CBiPS4 Sv4F F6)

    Spain Spanish Stem Cell Bank (ES)
    Disease:

    Normal

  31. FDCHDPi001-A (FDCHDP01)

    China Fudan University (FDCHDP)
    Disease:

    Tourette syndrome

  32. FDHPIi001-A

    China (WITHDRAWN) Fudan University (FDHPI)
    Disease:

    Neurodegeneration

  33. FJMUUHi001-A

    China Fujian Medical University Union Hospital (FJMUUH)
    Disease:

    Parkinson's disease 7

  34. GENEAe001-A (GENEA001 and SIVF01)

    Australia Genea (GENEA)
    Disease:

    Normal

  35. GENEAe002-A (GENEA003 and SIVF03)

    Australia Genea (GENEA)
  36. GENEAe003-A (SIVF04 and GENEA004)

    Australia Genea (GENEA)
  37. GENEAe004-A (SIVF05 and GENEA005)

    Australia Genea (GENEA)
  38. GENEAe005-A (SIVF06 and GENEA006)

    Australia Genea (GENEA)
  39. GENEAe006-A (SIVF07 and GENEA007)

    Australia Genea (GENEA)
  40. GENEAe007-A (GENEA008 and SIVF08)

    Australia Genea (GENEA)
  41. GENEAe008-A (GENEA009 and SIVF09)

    Australia Genea (GENEA)
  42. GENEAe009-A (SIVF10 and GENEA010)

    Australia Genea (GENEA)
  43. GENEAe010-A (SIVF11 and GENEA011)

    Australia Genea (GENEA)
  44. GENEAe011-A (SIVF12 and GENEA012)

    Australia Genea (GENEA)
  45. GENEAe012-A (SIVF13 and GENEA013)

    Australia Genea (GENEA)
  46. GENEAe014-A (GENEA029)

    United States Genea (GENEA)
    Disease:

    Normal

  47. IBPi001-A (HPrF iPSCs 20A)

    Czech Republic Institute of Biophysics of the Czech Academy of Sciences (IBP)
    Disease:

    Normal

  48. ICGi022-A-1 (SOD1-G128R_K7-4L-f and SOD1-G128R)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Amyotrophic lateral sclerosis

  49. ICGi030-A (HF2)

    Russia Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (ICG)
    Disease:

    Wilson disease

  50. IMBPASi001-A (iPSC-WFS1-#1)

    Poland Institute of Medical Biology of Polish Academy of Sciences (IMBPAS)
    Disease:

    Wolfram syndrome 1

  51. INNDSUi001-A (186-Nml-F-24)

    China Institute of Neuromuscular and Neurodegenerative Diseases, Shandong University (INNDSU)
    Disease:

    Normal

  52. KAUSTi008-F (KS4-iPSC#F)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Klinefelter's syndrome

  53. WAe001-A-F (H1X-59/H1.4-5)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Normal

  54. KMUGMCi006-F (TS271 #20 MT)

    Japan Kanazawa Medical University (KMUGMC)
    Disease:

    Tuberous sclerosis

  55. KUIMSe001-A (KhES-1)

    Japan Kyoto University (KUIMS)
    Disease:

    Normal

  56. KUIMSe002-A (KhES-2)

    Japan Kyoto University (KUIMS)
  57. KUIMSe003-A (KhES-3)

    Japan Kyoto University (KUIMS)
  58. KUIMSe003-A-1

    Japan Kyoto University (KUIMS)
  59. MCRIi001-A-1 (PB001-OI26)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Osteogenesis imperfecta

  60. MIZMe004-A (Miz-hES9)

    South Korea MizMedi Hospital (MIZM)
  61. MIZMe005-A (Miz-hES14)

    South Korea MizMedi Hospital (MIZM)
  62. MIZMe006-A (Miz-hES15)

    South Korea MizMedi Hospital (MIZM)
  63. MIZMe007-A (Miz-hES4)

    South Korea MizMedi Hospital (MIZM)
  64. MIZMe008-A (Miz-hES5)

    South Korea MizMedi Hospital (MIZM)
  65. MIZMe009-A (Miz-hES6)

    South Korea MizMedi Hospital (MIZM)
  66. MIZMe010-A (Miz-hES7)

    South Korea MizMedi Hospital (MIZM)
  67. MIZMe011-A (Miz-hES8)

    South Korea MizMedi Hospital (MIZM)
  68. MIZMe012-A (Miz-hES10)

    South Korea MizMedi Hospital (MIZM)
  69. MIZMe013-A (Miz-hES11)

    South Korea MizMedi Hospital (MIZM)
  70. MIZMe014-A (Miz-hES12)

    South Korea MizMedi Hospital (MIZM)
  71. MIZMe015-A (Miz-hES13)

    South Korea MizMedi Hospital (MIZM)
    Disease:

    Patau syndrome

  72. MUNIe001-A (CCTL 6)

    Czech Republic Masaryk University (MUNI)
  73. MUNIe001-A-1

    Czech Republic Masaryk University (MUNI)
  74. MUNIe002-A (CCTL 8)

    Czech Republic Masaryk University (MUNI)
  75. MUNIe002-A-1

    Czech Republic Masaryk University (MUNI)
  76. MUNIe003-A (CCTL 9)

    Czech Republic Masaryk University (MUNI)
  77. MUNIe003-A-1

    Czech Republic Masaryk University (MUNI)
  78. MUNIe004-A (CCTL 10)

    Czech Republic Masaryk University (MUNI)
  79. MUNIe004-A-1

    Czech Republic Masaryk University (MUNI)
  80. MUNIe005-A (CCTL 12)

    Czech Republic Masaryk University (MUNI)
  81. MUNIe005-A-1

    Czech Republic Masaryk University (MUNI)
  82. MUNIe006-A (CCTL 13)

    Czech Republic Masaryk University (MUNI)
  83. MUNIe006-A-1

    Czech Republic Masaryk University (MUNI)
  84. MUNIe007-A (CCTL 14)

    Czech Republic Masaryk University (MUNI)
  85. MUSCSDi001-A (iPSK3)

    United States Steve's Duncan Lab (MUSCSD)
    Disease:

    Normal

  86. NERCe002-A (chHES-90)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  87. NERCe002-A-1 (chHES-90-PLEX-ZsGreen)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  88. NERCe002-A-2 (chHES-90-PLEX-Luciferase)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  89. NERCe002-A-3 (chHES-90-pINDUCER20-tet-14-3-3ζ)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  90. NERCe003-A-1 (chHES-8-pINDUCER20-tet-CTNNB1)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  91. NERCe003-A-2 (chHES-8-pINDUCER10-tet-shβ-catenin)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  92. NERCe003-A-3 (chHES-8-KO-P53)

    China National Engineering and Research Center of Human Stem Cell (NERC)
    Disease:

    Normal

  93. NIMHi001-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Obsolete_parkinson's disease

  94. NIMHi002-A (BPPD02)

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Parkinson's disease

  95. NIMHi003-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Parkinson's disease

  96. NIMHi004-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal

  97. NIMHi005-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal

  98. NIMHi006-A

    India National Institute of Mental Health and Neurosciences (NIMH)
    Disease:

    Normal

  99. RCi002-A (FP5C-14 and RCi92)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  100. RCi002-B (FP5C-16 and RCi93)

    United Kingdom Pfizer Limited - Pfizer (PFIZ)
    Disease:

    Primary erythromelalgia

  101. RIi001-A (R.1.H.iPSC.1)

    Iran Royan Institute (RI)
  102. RIi002-A (BOM.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Normal

  103. RIi003-A (FHC.1.H.iPSC.3)

    Iran Royan Institute (RI)
    Disease:

    Familial hypercholesterolemia

  104. RIi004-A (GSD.1.H.iPSC.7)

    Iran Royan Institute (RI)
    Disease:

    Glycogen storage disease

  105. RIi005-A (TYR.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Tyrosinemia type 1

  106. RIi006-A (HER.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Cholestasis

  107. RIi007-A (R.1.H.iPSC.4)

    Iran Royan Institute (RI)
  108. RIi008-A (R.1.H.iPSC.9)

    Iran Royan Institute (RI)
  109. RIi009-A (RP2.H.iPSC.3)

    Iran Royan Institute (RI)
    Disease:

    Retinitis pigmentosa

  110. RIi010-A (LCA.1.H.iPSC.1)

    Iran Royan Institute (RI)
    Disease:

    Leber congenital amaurosis

  111. RIi011-A (USH.1.H.iPSC.6)

    Iran Royan Institute (RI)
    Disease:

    Usher syndrome

  112. RIi012-A (RP.1.H.iPSC.2)

    Iran Royan Institute (RI)
    Disease:

    Retinitis pigmentosa

  113. RIi013-A (ARMD.1.H.iPSC.2)

    Iran Royan Institute (RI)
    Disease:

    Age-related macular degeneration

  114. RIi014-A (LHON.1.H.iPSC.5)

    Iran Royan Institute (RI)
    Disease:

    Leber congenital amaurosis

  115. RIi015-A (CNS.1.H.iPSC.10)

    Iran Royan Institute (RI)
    Disease:

    Crigler-najjar syndrome

  116. RIi016-A (CNS.2.H.iPSC.7)

    Iran Royan Institute (RI)
    Disease:

    Crigler-najjar syndrome

  117. SALKe001-A (Cyth25)

    United States The Salk Institute for Biological Studies (SALK)
  118. SNUe004-A (SNUhES4)

    South Korea Seoul National University (SNU)
    Disease:

    Normal

  119. SNUe004-A-1

    South Korea Seoul National University (SNU)
    Disease:

    Normal

  120. SNUe005-A (SNUhES11)

    South Korea Seoul National University (SNU)
  121. SNUe005-A-1

    South Korea Seoul National University (SNU)
  122. SNUe006-A (SNUhES16)

    South Korea Seoul National University (SNU)
  123. SNUe006-A-1

    South Korea Seoul National University (SNU)
  124. SSMUe003-A (SH7)

    China Shanghai Second Medical University (SSMU)
  125. SSMUe004-A (SH4)

    China Shanghai Second Medical University (SSMU)
  126. SSMUe005-A (SH28)

    China Shanghai Second Medical University (SSMU)
  127. SSMUe006-A (SH35 and SH35a)

    China Shanghai Second Medical University (SSMU)
  128. SSMUe008-A (SH38)

    China Shanghai Second Medical University (SSMU)
  129. SSMUe009-A (SH39)

    China Shanghai Second Medical University (SSMU)
  130. SSMUe010-A (SH42)

    China Shanghai Second Medical University (SSMU)
  131. TISSUi001-A (HUMIMIC101, StemUse101 and SU101)

    Germany TissUse GmbH (TISSU)
    Disease:

    Normal

  132. UAZTi011-A (MKAZ3)

    United States University of Arizona (UAZT)
    Disease:

    Pontocerebellar hypoplasia type 1b

  133. UKHGi002-A (F-PKE (2))

    Germany Institute of Human Genetics Heidelberg (UKHG)
    Disease:

    Normal

  134. UKHGi002-B (F-PKE (3))

    Germany Institute of Human Genetics Heidelberg (UKHG)
    Disease:

    Normal

  135. ULBi002-A (Hel115.6)

    Belgium Université Libre de Bruxelles (ULB)
    Disease:

    Normal

  136. UPSFRi001-A (PB03)

    France Université Paris-Sud 11 (UPSFR)
  137. UPSFRi002-A (PB04)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  138. UPSFRi003-A (PB05-1)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  139. UPSFRi004-A (PB05)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  140. UPSFRi004-A-1 (PB05-1)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Beta thalassemia

  141. UPSFRi005-A (PB06)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Down syndrome

  142. UPSFRi005-A-1 (PB06-1)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Down syndrome

  143. UPSFRi006-A (PB07)

    France Université Paris-Sud 11 (UPSFR)
  144. UPSFRi007-A (PB08)

    France Université Paris-Sud 11 (UPSFR)
  145. UPSFRi008-A (PB09)

    France Université Paris-Sud 11 (UPSFR)
  146. UPSFRi009-A (PB10)

    France Université Paris-Sud 11 (UPSFR)
  147. UPSFRe001-A (CL01)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Chromosomal disease

  148. UPSFRe002-A (CL02)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Monogenic disease

  149. UPSFRe003-A (CL03)

    France Université Paris-Sud 11 (UPSFR)
    Disease:

    Chromosomal disease

  150. VIACe001-A (hESBGN-01 (BG01))

    United States Novocell, Inc. (VIAC)
  151. VIACe001-A-2 (BG01V)

    United States Novocell, Inc. (VIAC)
    Disease:

    Klinefelter syndrome

  152. VIACe002-A (hESBGN-02 (BG02))

    United States Novocell, Inc. (VIAC)
  153. VIACe003-A (hESBGN-03 (BG03))

    United States Novocell, Inc. (VIAC)
  154. WAe001-A (WA01 and H1)

    United States WiCell Research Institute (WA)
    Disease:

    Normal

  155. WAe007-A (H7 and WA07)

    United States WiCell Research Institute (WA)
    Disease:

    Normal

  156. WAe013-A (WA13 and H13)

    United States WiCell Research Institute (WA)
  157. WAe014-A (WA14 and H14)

    United States WiCell Research Institute (WA)
  158. WTSIi001-A (HPSI1213i-pahc_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  159. WTSIi037-A (HPSI0114i-zoxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  160. WTSIi038-A (HPSI1113i-ieki_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  161. WTSIi046-B (HPSI0214i-wibj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  162. WTSIi047-B (HPSI0814i-bokz_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  163. WTSIi049-A (HPSI0514i-wiii_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  164. WTSIi049-B (HPSI0514i-wiii_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  165. WTSIi052-A (HPSI1114i-ziyn_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  166. WTSIi053-A (HPSI0413i-corn_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  167. WTSIi054-B (HPSI0413i-nudd_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  168. WTSIi056-A (HPSI0513i-dipe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  169. WTSIi057-B (HPSI0513i-giuf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  170. WTSIi059-A (HPSI0513i-uilw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  171. WTSIi063-A (HPSI0613i-aevs_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  172. WTSIi068-B (HPSI0613i-giuo_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  173. WTSIi069-A (HPSI0613i-hegp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  174. WTSIi073-A (HPSI0314i-sojd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  175. WTSIi082-A (HPSI1013i-cups_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  176. WTSIi083-A (HPSI1213i-xuja_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  177. WTSIi085-A (HPSI1113i-eofe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  178. WTSIi086-A (HPSI0913i-coyi_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  179. WTSIi098-A (HPSI1213i-nekd_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  180. WTSIi102-A (HPSI0413i-iakz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  181. WTSIi102-B (HPSI0413i-iakz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  182. WTSIi103-A (HPSI1213i-nusw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  183. WTSIi104-A (HPSI0513i-coio_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  184. WTSIi104-B (HPSI0513i-coio_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  185. WTSIi105-A (HPSI0313i-airc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  186. WTSIi105-B (HPSI0313i-airc_66)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  187. WTSIi106-B (HPSI0613i-hikj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  188. WTSIi109-A (HPSI0413i-coxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  189. WTSIi109-B (HPSI0413i-coxy_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  190. WTSIi110-A (HPSI0713i-darw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  191. WTSIi111-A (HPSI0513i-euir_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  192. WTSIi112-A (HPSI0613i-funp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  193. WTSIi114-A (HPSI0513i-golb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  194. WTSIi115-A (HPSI0513i-iasn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  195. WTSIi116-A (HPSI0813i-iicq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  196. WTSIi117-A (HPSI0613i-liun_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  197. WTSIi118-A (HPSI0813i-meqo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  198. WTSIi119-A (HPSI0613i-oefg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  199. WTSIi120-A (HPSI0513i-oeoo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  200. WTSIi121-A (HPSI0413i-ougl_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  201. WTSIi121-B (HPSI0413i-ougl_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  202. WTSIi122-A (HPSI0413i-peop_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  203. WTSIi123-A (HPSI0713i-qimz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  204. WTSIi124-A (HPSI0713i-ruyv_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  205. WTSIi124-B (HPSI0713i-ruyv_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  206. WTSIi125-A (HPSI0413i-uahf_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  207. WTSIi126-A (HPSI0913i-vopm_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  208. WTSIi127-A (HPSI0413i-xekf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  209. WTSIi128-A (HPSI0413i-yuze_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  210. WTSIi129-A (HPSI0613i-zisa_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  211. WTSIi130-A (HPSI0713i-aehn_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  212. WTSIi131-A (HPSI0513i-aipt_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  213. WTSIi133-A (HPSI0713i-dard_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  214. WTSIi133-B (HPSI0713i-dard_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  215. WTSIi134-B (HPSI0513i-dulv_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  216. WTSIi137-A (HPSI0613i-lizq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  217. WTSIi137-B (HPSI0613i-lizq_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  218. WTSIi138-A (HPSI0414i-mita_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  219. WTSIi139-A (HPSI1113i-oaaz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  220. WTSIi140-A (HPSI0613i-oomz_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  221. WTSIi141-A (HPSI0613i-qanu_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  222. WTSIi142-A (HPSI0613i-qony_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  223. WTSIi144-A (HPSI0114i-wegi_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  224. WTSIi145-A (HPSI0813i-wots_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  225. WTSIi146-A (HPSI0613i-xosg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  226. WTSIi168-A (HPSI0214i-poih_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  227. WTSIi168-B (HPSI0214i-poih_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  228. WTSIi169-A (HPSI0614i-miaj_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  229. WTSIi170-A (HPSI1213i-tolg_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  230. WTSIi170-B (HPSI1213i-tolg_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  231. WTSIi171-A (HPSI0914i-zerv_7)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  232. WTSIi171-B (HPSI0914i-zerv_8)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  233. WTSIi172-A (HPSI0914i-laey_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  234. WTSIi172-B (HPSI0914i-laey_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  235. WTSIi173-A (HPSI0414i-naju_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  236. WTSIi174-A (HPSI0614i-paab_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  237. WTSIi175-A (HPSI1014i-tixi_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  238. WTSIi176-B (HPSI0714i-iudw_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  239. WTSIi177-A (HPSI0414i-xojn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  240. WTSIi178-B (HPSI0215i-fawm_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  241. WTSIi179-A (HPSI0314i-wigw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  242. WTSIi180-A (HPSI0514i-puie_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  243. WTSIi180-B (HPSI0514i-puie_5)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  244. WTSIi181-A (HPSI0514i-rutc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  245. WTSIi182-A (HPSI0614i-kegd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  246. WTSIi183-A (HPSI0414i-oaqd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  247. WTSIi183-B (HPSI0414i-oaqd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  248. WTSIi184-A (HPSI1014i-qayj_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  249. WTSIi184-B (HPSI1014i-qayj_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  250. WTSIi186-A (HPSI1014i-babz_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  251. WTSIi187-A (HPSI1013i-sita_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  252. WTSIi188-A (HPSI1014i-kefb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  253. WTSIi189-A (HPSI1014i-quls_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  254. WTSIi190-A (HPSI0914i-kajh_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  255. WTSIi191-A (HPSI0215i-oilg_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  256. ZJUi011-A (ZJULLi003-A and LSYMYH7iPS)

    China Zhejiang University (ZJU)
    Disease:

    Hypertrophic cardiomyopathy

  257. ZZUNEUi010-A (CMF001-A)

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Juvenile amyotrophic lateral sclerosis